|
|
Volumn 2, Issue 3, 2000, Pages 196-200
|
|
Management of idiopathic achalasia: short-term and long-term outcomes.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPARKINSON AGENT;
BOTULINUM TOXIN;
BALLOON DILATATION;
COST BENEFIT ANALYSIS;
ESOPHAGUS ACHALASIA;
HUMAN;
OUTCOME ASSESSMENT;
QUALITY OF LIFE;
REVIEW;
ANTI-DYSKINESIA AGENTS;
BALLOON DILATATION;
BOTULINUM TOXINS;
COST-BENEFIT ANALYSIS;
ESOPHAGEAL ACHALASIA;
HUMANS;
OUTCOME ASSESSMENT (HEALTH CARE);
QUALITY OF LIFE;
|
|
EID: 0034203706
PISSN: 15228037
EISSN: None
Source Type: Journal
DOI: 10.1007/s11894-000-0061-5 Document Type: Review |
|
Times cited : (11)
|
|
References (53)
|
